Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
26 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Viamet Pharmaceuticals, Inc. (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings, LLC is a biopharmaceutical company that discovers and develops metalloenzyme inhibitors and antifungal agents. The companys product pipeline includes clinical-stage compounds VT-1161 and VT-1129 and late-stage preclinical compound VT-1598. Its product VT-1161 VT-1161 is developed for the treatment of distal lateral subungual onychomycosis and for recurrent vulvovaginal candidiasis. Viamets product VT-1129 is developed for the treatment of cryptococcal meningitis.

Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, d

  
Source:
Document ID
GDPH187147D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Viamet Pharmaceuticals, Inc., Pharmaceuticals &Healthcare, Deal Details1112
  Venture Financing111
    Viamet Pharma Raises USD60 Million in Series D Venture Financing112
    Viamet Pharma Raises US$10 Million In Series C1 Financing131
    Viamet Pharma Secures Additional US$15 Million In Series B Financing142
  Partnerships161
    Viamet Pharma Enters into Agreement with MSGERC161
    Viamet Pharma Enters Into Co-Development Agreement With National Institutes of Health171
  Licensing Agreements181
    Innocrin Pharma Enters into Licensing Agreement with Viamet Pharma for Metallophile Technology181
    Dow AgroSciences Enters into Licensing Agreement with Viamet Pharma191
    Viamet Pharma Announces Option Licensing Agreement With Novartis Option Fund201
  Equity Offering211
    Viamet Pharma Withdraws IPO212
Viamet Pharmaceuticals, Inc. - Key Competitors231
Key Employees241
Locations And Subsidiaries251
  Head Office251
Appendix261
  Methodology261
  About GlobalData261
  Contact Us261
  Disclaimer261

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Viamet-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6683>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Viamet Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Viamet-Pharmaceuticals-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6683>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research